Urine Collection Devices Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Urine Collection Devices Market Report is Segmented by Product Type (Urine Collection Kits, and More), Patient (Adult and Pediatric), Application (Clinical Urinalysis, Drug Screening, and More), End User (Hospitals, Diagnostic Labs, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). Forecasts in Value (USD).

Urine Collection Devices Market Size and Share

Urine Collection Devices Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Urine Collection Devices Market Analysis by Mordor Intelligence

The Urine Collection Devices Market size was valued at USD 2.88 billion in 2026 and is estimated to grow from USD 3.04 billion in 2027 to reach USD 3.99 billion by 2032, at a CAGR of 5.56% during the forecast period (2027-2032).

The urine collection devices market is supported by rising urinary incontinence, broader urological care needs, and formal infection-prevention practices in hospitals. Demand is also shifting toward home-based care, where portable and self-managed systems are more relevant. Employers are widening urine-based drug screening programs, which raises requirements for secure collection and chain-of-custody features. Product development is moving beyond conventional catheter consumables through stabilization tubes, noninvasive pediatric systems, and point-of-care diagnostic workflows. Cost pressure from PVC and latex supply chains remains a concern, while fit problems and sample contamination can limit consistent use.

Key Report Takeaways

  • By product type, urine collection kits held 58.32% of the urine collection devices market share in 2026, while urine specimen bags are forecast to grow at a 7.54% CAGR through 2032.
  • By patient, adults held 48.54% share in 2026, while pediatric patients are projected to expand at a 7.89% CAGR through 2032.
  • By application, clinical urinalysis accounted for 39.54% share in 2026, while drug screening is forecast to grow at an 8.54% CAGR through 2032.
  • By end user, hospitals and clinics held 55.32% share in 2026, while diagnostic laboratories are forecast to grow at an 8.65% CAGR through 2032.
  • By geography, North America held 41.67% share in 2026, while Asia-Pacific is forecast to grow at a 6.54% CAGR through 2032.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Urine Collection Devices Market Segment Analysis

By Product Type:

Closed-System Kits Anchor Volume and Bags Support Home Care

Urine collection kits held 58.32% of the urine collection devices market share in 2026. The urine collection devices market relies on hospitals that use these kits within CAUTI prevention protocols that call for sterile, closed-transfer, single-use processes. This supports recurring purchasing even when generic products create price pressure. The product category remains closely tied to hospital formularies and institutional infection-control requirements.

Urine specimen bags are forecast to grow at a 7.54% CAGR through 2032. Portable suction-based designs are shifting bags from a bedside role toward home and ambulatory care. BD introduced its battery-powered PureWick portable system in November 2025, while Wellspect added the Surity urinary management system to its US offering in August 2026. Cups and containers serve drug screening, pregnancy testing, and standard urinalysis, while the VACUETTE Urine STB Tube maintains key parameters for up to 72 hours at room temperature. ISO 13485 and FDA quality-system requirements raise the compliance burden across these product categories.

Need more granular breakdown of segment shares?

Get tailored market insights for your requirements.

Urine Collection Devices Market Share by Product Type, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Urine Collection Devices Market Share by Product Type, 2026

By Patient:

Adult Care Provides Volume While Pediatric Systems Expand

Adult patients held 48.54% of sector revenue in 2026. In the urine collection devices market, stress urinary incontinence, benign prostatic hyperplasia, and post-surgical catheterization support adult demand. These needs occur in hospitals, long-term care facilities, and private homes. Workplace drug testing also requires standardized collection supplies, making adult collection needs central to the urine collection devices industry.

Pediatric patients are forecast to grow at a 7.89% CAGR through 2032. In November 2026, Nuwellis secured exclusive US distribution rights for the Zorro-Flow pediatric system. The FDA-registered Class II device uses soft medical-grade silicone for neonates and young children. A 2026 Pediatric Research study supported the accuracy of the Specturi noninvasive neonatal collector for several urinary measures[3]. India's CDSCO classifies open-ended and closed-ended adhesive infant collection bags as regulated medical devices.

By Application:

Urinalysis Leads While Drug Screening Grows Faster

Clinical urinalysis accounted for 39.54% of the urine collection devices market size in 2026. It is used frequently in emergency medicine, nephrology, endocrinology, and primary testing workflows. The urine collection devices market depends on standardized containers for consistent handling across laboratories and point-of-care sites. AI-assisted analyzers can measure several metabolic markers from a urine sample and broaden chronic disease monitoring.

Drug screening is forecast to grow at an 8.54% CAGR through 2032. Quest Diagnostics reported much higher fentanyl positivity in random workforce testing than in pre-employment tests. Employers need secure containers for multi-panel testing, including tamper-evident construction, adulterant screening, and chain-of-custody labeling. Pregnancy testing and clinical research remain additional applications, while home-based kits can dispatch preserved samples to central laboratories. The urine collection devices industry is increasingly shaped by these higher-specification requirements.

Segment this market the way your business does.

Get tailored market insights for your requirements.

Urine Collection Devices Market Share by Application, 2026
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Urine Collection Devices Market Share by Application, 2026

By End User:

Hospitals Remain Largest While Laboratories Increase Demand

Hospitals and clinics held 55.32% of sector revenue in 2026. The urine collection devices market in hospitals reflects CAUTI prevention specifications for closed catheter kits and anti-reflux drainage bags. CDC guidance supports careful catheter selection and maintenance practices. The reported CAUTI intervention results show how institutional programs can sustain compliant procurement.

Diagnostic laboratories are forecast to grow at an 8.65% CAGR through 2032. Rising clinical chemistry, microbiology, and drug screening volumes require standardized formats for automated systems. SARSTEDT's NFT needle-free transfer system uses a pierceable membrane that reseals after transfer. Home healthcare also expands as payers reimburse home-use catheterization supplies, while Coloplast reported 5% organic Continence Care growth in FY2026. Ambulatory centers and occupational health clinics add further demand for dedicated collection supplies.

Geography Analysis

North America

North America held 41.67% of regional revenue in 2026. The urine collection devices market in North America is supported by insurance reimbursement, established CAUTI prevention programs, and product development. BD stated that its Broken Bow facility received more than USD 50 million in investment since 2020. The facility produces Vacutainer tubes and urine collection products at high volume. DOT requirements sustain urine testing for safety-sensitive transportation workers. Expanding fentanyl testing also increases interest in secure specimen containers. In November 2025, Hollister announced expanded Medicare access to closed-system intermittent catheters for certain spinal-cord-injury beneficiaries from January 2026. Canada and Mexico add demand through private hospital growth and cross-border distribution networks.

Asia-Pacific

Asia-Pacific is forecast to grow at a 6.54% CAGR through 2032. The urine collection devices market in Asia-Pacific benefits as hospital expansion, aging populations, and public quality programs increase single-use device adoption. India is expanding hospital infrastructure through programs including Ayushman Bharat. People aged 60 years and above are projected to represent 11% of India's population by 2026. India's Medical Devices Rules, 2017, and ISO 13485 alignment shape compliance expectations. China adds demand through hospital buildouts and higher surgical volumes. Japan and Australia support premium devices such as hydrophilic-coated catheters and electronic urine meters. Continence Health Australia reported 7.2 million Australians living with incontinence in 2025. South Korea's medical technology exports broaden the region's supply base.

Europe, Middle East and Africa, and South America

Europe relies on advanced systems in Germany, NHS procurement in the United Kingdom, and EU MDR compliance. The urine collection devices market size in these countries benefits from rising home care budgets and recovering elective procedures. A 2025 study estimated that 55 million to 60 million Europeans live with urinary incontinence. The EU MDR favors products supported by clinical evidence and can raise entry barriers. GCC countries are expanding hospital capacity under national health plans. A 2025 meta-analysis estimated urinary incontinence prevalence among adult women in Africa at 24% across 22 studies. South Africa's private hospital growth adds to the regional demand base. Brazil leads South American demand through expanding private hospital groups and surgical activity. Argentina's device manufacturing base is starting to supply nearby Latin American markets.

Urine Collection Devices Market Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market Concentration

Urine Collection Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The urine collection devices market is moderately concentrated, with BD, Coloplast, ConvaTec, and Hollister holding established positions in institutional channels. Their positions rest on formulary relationships, distribution reach, and proprietary product platforms. BD stated that PureWick was the leading external catheter used in US hospitals. The company also reported more than 55 million units sold and more than 4,500 hospital accounts. Coloplast reported that its Continence Care business grew 7% organically in FY2026, supported by double-digit growth in the United States. Product differentiation includes hydrophilic surfaces, drainage designs, and no-touch handling.

The urine collection devices market also reflects active competition around closed transfer, sample integrity, and biofilm management. SARSTEDT's NFT Urine Monovette uses a needle-free transfer format aligned with ISO 23908 safety principles. This type of design can create switching costs in laboratories focused on staff safety and contamination reduction. In January 2025, Coloplast launched Luja Female in the United States with Micro-hole Zone Technology. The product uses more than 50 micro-holes to support bladder emptying without catheter repositioning. In September 2025, Coloplast placed Luja at the center of its Impact4 strategy.

Portfolio changes are also creating openings for focused suppliers. Teleflex agreed in December 2025 to sell its Acute Care, Interventional Urology, and OEM businesses for USD 2.03 billion. The OEM divestiture to Montagu and Kohlberg was completed in August 2026 for USD 1.5 billion. Nuwellis used an exclusive distribution agreement to address neonatal collection needs. ConvaTec launched Cure Aqua in September 2026 for female, male, and pediatric users. The product uses DEHP/DINP-free materials and a no-touch sleeve. These moves place greater emphasis on safety, comfort, and coverage across patient anatomies.

Urine Collection Devices Industry Leaders

  1. Becton, Dickinson and Company

  2. Thermo Fisher Scientific

  3. Abbott

  4. F. Hoffmann-La Roche Ltd

  5. Medline Industries, LP

  6. *Disclaimer: Major Players sorted in no particular order

Urine Collection Devices Market Companies Covered in this Report

  • Abbott Laboratories
  • ANGIPLAST PVT. LTD.
  • B. Braun
  • Beckton Dickinson
  • BioDerm Inc.
  • Cardinal Health
  • Coloplast
  • Consure Medical
  • Convatec
  • Roche
  • Greiner Bio-One GmbH
  • Hollister
  • Medline Industries
  • POLYMED
  • QIAGEN
  • Sarstedt
  • Teleflex
  • Thermo Fisher Scien

Recent Industry Developments in Urine Collection Devices Market

  • November 2026: Nuwellis, Inc. secured exclusive US distribution rights for the Zorro-Flow® pediatric urine collection system, a FDA-registered Class II non-invasive device using soft medical-grade silicone designed for neonates and young children, full US commercialization is planned from Q1 2027. The product eliminates catheterization and suprapubic aspiration in critically ill small babies, directly addressing the neonatal urine collection gap in PICUs and CVICUs where Nuwellis has established relationships at 47 of the top US children's hospitals.
  • September 2026: ConvaTec launched Cure Aqua, a ready-to-use hydrophilic intermittent catheter, in the US and Canada. Available in female, male, and pediatric options, requiring no activation step, free from DEHP/DINP and BPA, and featuring a no-touch handling sleeve to reduce contamination risk, additional market launches outside North America are planned.
  • August 2026: Wellspect HealthCare completed its US Surity portfolio with the launch of the Surity Urinary Management System, an at-home suction-based external urine collection device targeting over 13 million Americans and their caregivers managing urinary incontinence, with quiet overnight operation designed to minimize caregiver burden.

Table of Contents for Urine Collection Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Urinary Incontinence and Urological Disorder Burden
    • 4.2.2 Hospital Catheter-Reduction and CAUTI-Prevention Programs
    • 4.2.3 Expansion of Home Healthcare and Long-Term Care
    • 4.2.4 Decentralized Diagnostics and Urine-Based Biomarker Testing
    • 4.2.5 Pediatric and Neonatal Urine Management Needs
    • 4.2.6 Integrated Closed-Transfer and Sample-Integrity Designs
  • 4.3 Market Restraints
    • 4.3.1 Skin Injury, Leakage, and Anatomical-Fit Variability
    • 4.3.2 Contamination and Pre-Analytical Handling Errors
    • 4.3.3 Reimbursement, Procurement, and Training Friction
    • 4.3.4 Material, Tariff, and Sustainability Cost Pressure
  • 4.4 Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat Of New Entrants
    • 4.7.2 Bargaining Power Of Buyers
    • 4.7.3 Bargaining Power Of Suppliers
    • 4.7.4 Threat Of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Urine Collection Kits
    • 5.1.2 Urine Specimen Bags
    • 5.1.3 Urine Cups and Containers
  • 5.2 By Patient
    • 5.2.1 Adult
    • 5.2.2 Pediatric
  • 5.3 By Application
    • 5.3.1 Clinical Urinalysis
    • 5.3.2 Drug Screening
    • 5.3.3 Pregnancy Testing
    • 5.3.4 Clinical Research and Studies
  • 5.4 By End User
    • 5.4.1 Hospitals and Clinics
    • 5.4.2 Diagnostic Laboratories
    • 5.4.3 Home Healthcare
    • 5.4.4 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(Includes Global Level Overview, Market Level Overview, Core Segments, Financials As Available, Strategic Information, Market Rank/Share For Key Companies, Products & Services, And Recent Developments)}
    • 6.3.1 Abbott
    • 6.3.2 ANGIPLAST PVT. LTD.
    • 6.3.3 B. Braun Melsungen AG
    • 6.3.4 Becton, Dickinson and Company
    • 6.3.5 BioDerm Inc.
    • 6.3.6 Cardinal Health
    • 6.3.7 Coloplast A/S
    • 6.3.8 Consure Medical Pvt. Ltd.
    • 6.3.9 ConvaTec Group PLC
    • 6.3.10 F. Hoffmann-La Roche Ltd
    • 6.3.11 Greiner Bio-One GmbH
    • 6.3.12 Hollister Incorporated
    • 6.3.13 Medline Industries, LP
    • 6.3.14 POLYMED
    • 6.3.15 QIAGEN N.V.
    • 6.3.16 SARSTEDT AG & Co. KG
    • 6.3.17 Teleflex Incorporated
    • 6.3.18 Thermo Fisher Scien

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment

Global Urine Collection Devices Market Report Scope

According to the report’s scope, urine collection devices are medical products used to collect, contain, and sometimes measure urine from patients. They include urinary catheters, drainage bags, and external collection systems.

The urine collection devices market is segmented into product type, patient, application, end user, and geography. By product type, the market is segmented into urine collection kits, specimen bags, and cups and containers. By patient, the market is segmented into adult and pediatric. By application, the market is segmented into clinical urinalysis, drug screening, pregnancy testing, and clinical research. By end user, the market is segmented into hospitals, diagnostic labs, home healthcare, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers values (USD) for all the above segments.  

Segmentation Overview

By Product Type
Urine Collection Devices Market segmentation breakdown
Urine Collection Kits
Urine Specimen Bags
Urine Cups and Containers
By Patient
Urine Collection Devices Market segmentation breakdown
Adult
Pediatric
By Application
Urine Collection Devices Market segmentation breakdown
Clinical Urinalysis
Drug Screening
Pregnancy Testing
Clinical Research and Studies
By End User
Urine Collection Devices Market segmentation breakdown
Hospitals and Clinics
Diagnostic Laboratories
Home Healthcare
Other End Users
Geography
Urine Collection Devices Market segmentation breakdown
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Urine Collection Devices Market segmentation breakdown
By Product Type Urine Collection Kits
Urine Specimen Bags
Urine Cups and Containers
By Patient Adult
Pediatric
By Application Clinical Urinalysis
Drug Screening
Pregnancy Testing
Clinical Research and Studies
By End User Hospitals and Clinics
Diagnostic Laboratories
Home Healthcare
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America

Key Questions Answered in the Report

What is driving growth in urine collection devices?

Demand is supported by rising urinary incontinence, larger home-care needs, CAUTI prevention programs, and more frequent diagnostic and workforce urine-testing workflows.

How large is the urine collection devices market?

The market is projected to move from USD 3.04 billion in 2027 to USD 3.99 billion by 2032, representing a 5.56% CAGR.

Which product type leads urine collection device demand?

Urine collection kits held 58.32% share in 2026 because hospitals depend on sterile closed-system products within established infection-control protocols.

Which application is expanding fastest for urine collection devices?

Drug screening is forecast to grow at an 8.54% CAGR through 2032. Workplace testing requires tamper-evident containers and clear chain-of-custody handling.

Which end user will grow fastest through 2032?

Diagnostic laboratories are forecast to grow at an 8.65% CAGR as clinical chemistry, microbiology, and drug screening require standardized formats for automation.

Which region has the strongest growth outlook?

Asia-Pacific is forecast to expand at a 6.54% CAGR through 2032, supported by hospital investment, aging populations, surgical volume, and quality-system requirements.

Page last updated on: